GENE ONLINE|News &
Opinion
Blog

Biomedical Advanced Research and Development Authority
BARDA Exercises $23.8 Million to Support Phase 3 Trial of Vedanta’s Encouraging Microbiome Therapy
2021-10-07
R&D
BARDA Funds Development of Live Biotherapeutic Product Against C. difficile Infections
2020-10-05
COVID-19: Early Data Shows Regeneron’s Antibody Cocktail Curbs Virus, Speeds Recovery
2020-10-01
COVID-19 Vaccine: Moderna Begins Phase 3 COVE Study of mRNA-1273
2020-07-27
FDA Revokes Emergency Authorization of Malarial Drugs for Treating COVID-19
2020-06-18
SAB Biotherapeutics Mines Cow’s Antibodies for Treating COVID-19
2020-06-17
COVID-19: AstraZeneca Receives $1B from BARDA to Develop Oxford’s Coronavirus Vaccine
2020-05-23
COVID-19: Moderna Registers Positive Phase 1 Results for mRNA Vaccine
2020-05-18
COVID-19 Vaccine: Moderna Gets $483M Funding Boost from BARDA
2020-04-17
Seqirus’ AUDENZTM, a Vaccine against Potential Flu Epidemic Gets FDA Approval
2020-02-05
LATEST
Comparative Analysis of Tirzepatide (Zepbound/Mounjaro) and Semaglutide (Wegovy) for Weight Loss
2025-05-12
Donald Trump’s “Most Favored Nation” Executive Order on Drug Pricing
2025-05-12
Discover Investment Opportunities & Innovation at International Healthcare Week in Hong Kong from May
2025-05-12
The Buffett Paradox: Cola, Happiness, and a Biotech Longevity Enigma
2025-05-11
President to Sign Executive Order on Trade Enforcement Monday Morning
2025-05-11
Trump to Sign Executive Order Linking U.S. Drug Prices to International Levels.
2025-05-11
Podcast Highlights Agile Biopharmaceutical Firms’ Strategies for Navigating Complex Clinical Trials
2025-05-11
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top